Stallergenes
Records under this name other than the patents Stallergenes holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Showing 1 to 4 of 4 · Back to Stallergenes
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,285,650 | Cloning and sequencing of the allergen Dac g5 of Dactylis glomerata pollen, its preparation and its use Term ended Term ended Nov 12, 2022 · From the USPTO record | Term ended | Term ended Nov 12, 2022 | From the USPTO record |
| US 9,822,185 | Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosa Lapsed on the fee record Ended Nov 21, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 21, 2021 | From the USPTO record |
| US 9,480,748 | Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance Lapsed on the fee record Ended Nov 1, 2020 · From the USPTO record | Lapsed on the fee record | Ended Nov 1, 2020 | From the USPTO record |
| US 9,187,568 | Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route Lapsed on the fee record Ended Nov 17, 2019 · From the USPTO record | Lapsed on the fee record | Ended Nov 17, 2019 | From the USPTO record |